MedTrace Logo

Oral Supplementation of Astaxanthin on Skin Photoaging, Hydration and Elasticity

NCT05882084 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-07-25

No results posted yet for this study

Summary

This study is a double-blind placebo controlled study to assess whether oral astaxanthin can improve skin hydration, skin elasticity, improve skin pigmentation, and reduce facial redness.

Conditions

  • Photoaging

Interventions

DIETARY_SUPPLEMENT

Astaxanthin 6 mg daily

Astaxanthin at 6 mg is given for daily ingestion and compared against placebo.

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • AstaReal

    collaborator UNKNOWN

  • Integrative Skin Science and Research

    lead INDUSTRY

Principal Investigators

  • Raja Sivamani, MD · Integrative Skin Science and Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2023-09-30
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05882084 on ClinicalTrials.gov